Key result
Novel CRISPR/Cas12a aptasensor enables ultrasensitive Mpox A29 protein detection down to ~0.28 ng/mL.
Why the study?
Adequate and appropriate diagnostic procedures for Mpox virus are urgently needed due to its emergence and rapid spread.
The developed CRISPR/Cas12a-mediated aptasensor provides a highly sensitive and stable method for detecting the Mpox virus A29 antigen.
Premature for clinical diagnostics; hypothesis-generating for CRISPR-based Mpox antigen detection pending human validation.
The emergence and rapid spread of Mpox (formerly monkeypox) have caused significant societal challenges. Adequate and appropriate diagnostics procedures are an urgent necessity. Herein, we discover a pair of aptamers through the systematic evolution of ligands by exponential enrichment (SELEX) that exhibit high affinity and bind to different sites towards the A29 protein of the Mpox virus . Subsequently, we propose a facile, sensitive, convenient CRISPR/Cas12a-mediated aptasensor for detecting the A29 antigen. The procedure employs the bivalent aptamers recognition, which induces the formation of a proximity switch probe and initiates subsequent cascade strand displacement reactions, then triggers CRISPR/Cas12a DNA trans-cleavage to achieve the sensitive detection of Mpox. Our method enables selective and ultrasensitive evaluation of the A29 protein within the range of 1 ng mL −1 to 1 μg mL −1 , with a limit of detection (LOD) at 0.28 ng mL −1 . Moreover, spiked A29 protein recovery exceeds 96.9%, while the detection activity remains above 91.9% after six months of storage at 4 °C. This aptasensor provides a novel avenue for exploring clinical diagnosis in cases involving Mpox as facilitating development in various analyte sensors.
No takes yet. Share an insight, caveat, or question.
Han et al. (2024) studied Mpox virus. CRISPR/Cas12a-mediated aptasensor was evaluated on Detection of A29 protein of the Mpox virus. A novel CRISPR/Cas12a-mediated aptasensor enabled selective and ultrasensitive detection of the Mpox virus A29 protein with a limit of detection of 0.28 ng mL-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: